Bowen Matthew bought GLUE
April 6, 2026 · Form 4 insider transaction
Bowen Matthew bought 4,300 shares of Monte Rosa Therapeutics, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
4,300
Price
N/A
Total value
N/A
InsiderBowen Matthew
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateApril 6, 2026
Filing dateApril 7, 2026
Shares owned after25,904
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units ("RSUs") granted under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 25% of the RSUs shall vest on April 6, 2027, with the remainder vesting in 3 equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date.